Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia.

Villegas MV, Lolans K, del Rosario Olivera M, Suarez CJ, Correa A, Queenan AM, Quinn JP; Colombian Nosocomial Resistance Study Group.

Antimicrob Agents Chemother. 2006 Jan;50(1):226-9.

2.

Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.

Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, Glover J, Velez JD, Castañeda CR, Recalde M, Livermore DM.

J Clin Microbiol. 2004 Nov;42(11):5094-101.

3.

Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.

Khosravi Y, Tee Tay S, Vadivelu J.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):294-6. doi: 10.1016/j.diagmicrobio.2010.02.010. Epub 2010 May 11.

PMID:
20462725
4.

First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.

Van der Bij AK, Van Mansfeld R, Peirano G, Goessens WH, Severin JA, Pitout JD, Willems R, Van Westreenen M.

Int J Antimicrob Agents. 2011 Jun;37(6):513-8. doi: 10.1016/j.ijantimicag.2011.02.010. Epub 2011 Apr 14.

PMID:
21497065
5.

Integrons containing the VIM-2 metallo-beta-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals.

Yu YS, Qu TT, Zhou JY, Wang J, Li HY, Walsh TR.

J Clin Microbiol. 2006 Nov;44(11):4242-5. Epub 2006 Sep 27.

6.

Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.

Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.

J Antimicrob Chemother. 2013 Aug;68(8):1772-80. doi: 10.1093/jac/dkt098. Epub 2013 Apr 14.

PMID:
23587654
7.
8.

Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN.

Int J Antimicrob Agents. 2005 Jan;25(1):57-61.

PMID:
15620827
9.

Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.

Martins AF, Zavascki AP, Gaspareto PB, Barth AL.

Infection. 2007 Dec;35(6):457-60. Epub 2007 Nov 21.

PMID:
18034208
10.

Preferential selection of IMP and VIM metallo-beta-lactamases by imipenem in Pseudomonas aeruginosa.

Walsh F, Bracher S, Turner P, Amyes S.

Chemotherapy. 2007;53(6):407-9. Epub 2007 Oct 15.

PMID:
17934261
11.

Carbapenem-resistant Pseudomonas aeruginosa-carrying VIM-2 metallo-beta-lactamase determinants, Croatia.

Sardelic S, Pallecchi L, Punda-Polic V, Rossolini GM.

Emerg Infect Dis. 2003 Aug;9(8):1022-3. No abstract available.

12.

Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.

Senda K, Arakawa Y, Nakashima K, Ito H, Ichiyama S, Shimokata K, Kato N, Ohta M.

Antimicrob Agents Chemother. 1996 Feb;40(2):349-53.

13.

Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.

Juan C, Beceiro A, Gutiérrez O, Albertí S, Garau M, Pérez JL, Bou G, Oliver A.

Antimicrob Agents Chemother. 2008 Oct;52(10):3589-96. doi: 10.1128/AAC.00465-08. Epub 2008 Jul 21.

14.
15.

Study of metallo-beta-lactamase production in clinical isolates of Pseudomonas aeruginosa.

Agrawal G, Lodhi RB, Kamalakar UP, Khadse RK, Jalgaonkar SV.

Indian J Med Microbiol. 2008 Oct-Dec;26(4):349-51.

16.

Spread of integron-associated VIM-type metallo-beta-lactamase genes among imipenem-nonsusceptible Pseudomonas aeruginosa strains in Greek hospitals.

Giakkoupi P, Petrikkos G, Tzouvelekis LS, Tsonas S, Legakis NJ, Vatopoulos AC; WHONET Greece Study Group.

J Clin Microbiol. 2003 Feb;41(2):822-5.

17.

Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.

Minami S, Akama M, Araki H, Watanabe Y, Narita H, Iyobe S, Mitsuhashi S.

J Antimicrob Chemother. 1996 Mar;37(3):433-44.

PMID:
9182100
18.

[Prevalence of metallo-beta-lactamase in carbapenem resistant Pseudomonas aeruginosa at a university hospital of Buenos Aires City].

Pagniez G, Radice M, Cuirolo A, Rodríguez O, Rodríguez H, Vay C, Famiglietti A, Gutkind G.

Rev Argent Microbiol. 2006 Jan-Mar;38(1):33-7. Spanish.

PMID:
16784133
19.

VIM-2 beta-lactamase in Pseudomonas aeruginosa isolates from Zagreb, Croatia.

Bosnjak Z, Bedenić B, Mazzariol A, Jarza-Davila N, Suto S, Kalenić S.

Scand J Infect Dis. 2010 Mar;42(3):193-7. doi: 10.3109/00365540903426582.

PMID:
20001226
20.

Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya.

Pitout JD, Revathi G, Chow BL, Kabera B, Kariuki S, Nordmann P, Poirel L.

Clin Microbiol Infect. 2008 Aug;14(8):755-9. doi: 10.1111/j.1469-0691.2008.02030.x.

Supplemental Content

Support Center